A detailed history of State Of Wisconsin Investment Board transactions in Amgen Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 290,566 shares of AMGN stock, worth $93.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
290,566
Previous 294,405 1.3%
Holding current value
$93.8 Million
Previous $83.7 Million 8.46%
% of portfolio
0.25%
Previous 0.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $1.01 Million - $1.23 Million
-3,839 Reduced 1.3%
290,566 $90.8 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $1.17 Million - $1.41 Million
4,336 Added 1.49%
294,405 $83.7 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $341,870 - $385,671
-1,337 Reduced 0.46%
290,069 $83.5 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $1.52 Million - $1.89 Million
-6,974 Reduced 2.34%
291,406 $78.3 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $1.06 Million - $1.25 Million
4,943 Added 1.68%
298,380 $66.2 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $2.53 Million - $3.08 Million
11,199 Added 3.97%
293,437 $70.9 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $7.69 Million - $9.77 Million
-33,570 Reduced 10.63%
282,238 $74.1 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $18 Million - $20.3 Million
-80,047 Reduced 20.22%
315,808 $71.2 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $4.65 Million - $5.18 Million
-20,168 Reduced 4.85%
395,855 $96.3 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $5.49 Million - $6.07 Million
25,021 Added 6.4%
416,023 $101 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $33.6 Million - $38.5 Million
-169,093 Reduced 30.19%
391,002 $88 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $28 Million - $32.7 Million
131,679 Added 30.74%
560,095 $119 Million
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $12.6 Million - $14 Million
-54,094 Reduced 11.21%
428,416 $104 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $41.5 Million - $48.3 Million
186,791 Added 63.17%
482,510 $120 Million
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $50.4 Million - $60 Million
-232,888 Reduced 44.06%
295,719 $68 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $16.4 Million - $18.3 Million
70,069 Added 15.28%
528,607 $134 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $25.6 Million - $31.4 Million
-129,559 Reduced 22.03%
458,538 $108 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $13.3 Million - $17.6 Million
-72,765 Reduced 11.01%
588,097 $119 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $7.13 Million - $9.17 Million
37,694 Added 6.05%
660,862 $159 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $30.3 Million - $36.3 Million
174,001 Added 38.74%
623,168 $121 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $17.5 Million - $20.6 Million
-105,254 Reduced 18.98%
449,167 $82.8 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $1.15 Million - $1.3 Million
6,365 Added 1.16%
554,421 $105 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $10.2 Million - $11.9 Million
-57,004 Reduced 9.42%
548,056 $107 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $10.6 Million - $11.9 Million
-56,940 Reduced 8.6%
605,060 $125 Million
Q2 2018

Aug 03, 2018

SELL
$166.05 - $186.51 $6.55 Million - $7.36 Million
-39,449 Reduced 5.62%
662,000 $122 Million
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $1.9 Million - $2.22 Million
-11,212 Reduced 1.57%
701,449 $120 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $23.1 Million - $25.8 Million
-136,616 Reduced 16.09%
712,661 $124 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $142 Million - $162 Million
849,277
849,277 $158 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.